Study Summary
This trial is testing a new drug for safety in people with mild memory problems or Alzheimer's. The drug is given at different levels to different groups to find a safe dose. Healthy older adults may also participate.
- Alzheimer's Disease
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
9 Primary · 0 Secondary · Reporting Duration: Up to approximately 297 days
Trial Safety
Phase-Based Safety
Trial Design
2 Treatment Groups
MK-2214
1 of 2
Placebo
1 of 2
Experimental Treatment
Non-Treatment Group
48 Total Participants · 2 Treatment Groups
Primary Treatment: MK-2214 · Has Placebo Group · Phase 1
Trial Logistics
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 50 - 80 · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
| California | 100.0% |
What site did they apply to?
| California Clinical Trials Medical Group managed by PAREXEL-PAREXEL International ( Site 0007) | 100.0% |
What portion of applicants met pre-screening criteria?
| Did not meet criteria | 100.0% |
Why did patients apply to this trial?
- "Tried diffrent medication, nothing seems to help"
How many prior treatments have patients received?
| 0 | 100.0% |
Frequently Asked Questions
Are any new participants being accepted into this examination?
"Affirmative, the clinical trial is still in search of participants. Initially published on September 20th 2022, this medical research was last updated on November 15th of that same year (2022)." - Anonymous Online Contributor
What potential risks does MK-2214 pose to individuals?
"Due to the limited amount of data regarding MK-2214's safety and efficacy, our team assign this medication a score of 1 on their risk assessment scale." - Anonymous Online Contributor
How many locations are overseeing the implementation of this trial?
"This trial is being run out of 8 strategic locations, including Hallandale Beach, Long Beach and Hollywood. To reduce the burden on participants, it is advised to select a clinic close by when enrolling in this study." - Anonymous Online Contributor
Does eligibility for this research study extend to those under the age of 30?
"Elderly patients aged between 50 and 80 are currently being recruited for this medical trial." - Anonymous Online Contributor
How many volunteers have registered for the trial thus far?
"Affirmative. Clinicaltrials.gov reveals that this medical trial, which initially went live on September 20th 2022, is actively looking for research participants. The experiment requires 48 patients to be recruited from 8 different clinical sites." - Anonymous Online Contributor
What is the eligibility criteria for participation in this experiment?
"Alzheimer's Disease sufferers aged 50 to 80 are currently being recruited for this medical trial. To be eligible, participants must demonstrate general good health, have a BMI between 18.5-35 kg/m2, display gradual decline in mental and physical function over the course of one year prior to screening with MMSE scores >12 and <28 as well as MHIS score <4 at the pre-study visit." - Anonymous Online Contributor